Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linperlisib Monotherapy in Relapsed/Refractory Follicular Lymphoma
NCT04379167Phase 2Unknown
- Sponsor
- Yingli Pharma
- Start
- Dec 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of linperlisib in follicular lymphoma (FL), sponsored by Yingli Pharma. Status: unknown.
02
Drugs
linperlisib
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT04379167.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04379167.